Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 1999;81:153-159; doi:10.1136/hrt.81.2.153
Copyright © 1999 BMJ Publishing Group Ltd & British Cardiovascular Society

Heart 1999;81:153-159 ( February )

Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course

Y Yazaki,a M Isobe,b W Takahashi,a H Kitabayashi,b O Nishiyama,a M Sekiguchi,b T Takemuraa

a Division of Cardiology, National East Nagano Hospital, Nagano, Japan, b First Department of Internal Medicine, Shinshu University, Asahi 3-1-1, Matsumoto 390, Japan

Correspondence to: Dr Isobe.

Accepted for publication 7 September 1998

Objective---To determine the clinical and prognostic value of identifying metabolic abnormalities of myocardial fatty acid metabolism in idiopathic dilated cardiomyopathy using iodine-123 beta -methyl-iodophenyl pentadecanoic acid (123I BMIPP).
Setting---Cardiac care division in national hospital.
Patients---32 consecutive patients with idiopathic dilated cardiomyopathy in whom both 123I BMIPP and thallium-201 myocardial single photon emission computed tomography were performed.
Methods---The uptake of each tracer was scored visually from 0 (normal) to 3 (defect) in 17 segments (eight basal, eight midventricular, and one apical). A total score for all 17 segments was compared with clinicopathological variables. Prognostic value of mismatches between the two tracers were also evaluated.
Results---The 123I BMIPP total score was correlated with pulmonary capillary wedge pressure (r = 0.68, p < 0.001), left ventricular end diastolic pressure (r = 0.65, p < 0.001), percentage fractional shortening at six months' follow up (r = -0.58, p = 0.001), myocyte diameter (r = 0.66, p < 0.001), and percentage area of interstitial fibrosis (r = 0.69, p < 0.001) measured by morphometry in the biopsy specimens. During a mean (SD) follow up of 20 (11) months, deterioration of the New York Heart Association functional class was observed in 11 of the 32 patients; four of these died. Segments with a greater decrease in 123I BMIPP than thallium-201 uptake (type B mismatching) were often observed in patients with deterioration (88/187, 29% v 58/357, 16%; p < 0.001).
Conclusions---The extent of the abnormality of myocardial fatty acid metabolism in idiopathic dilated cardiomyopathy reflects the severity of haemodynamic deterioration and histopathological changes. Type B mismatching is one of the important prognostic indicators in idiopathic dilated cardiomyopathy.

Keywords: idiopathic dilated cardiomyopathy; fatty acid metabolism; beta -methyl-iodophenyl pentadecanoic acid


© 1999 by Heart

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Witteles, R. M., Fowler, M. B. (2008). Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options. J Am Coll Cardiol 51: 93-102 [Abstract] [Full Text]  
  • Lopaschuk, G. D. (2006). Optimizing cardiac Fatty Acid and glucose metabolism as an approach to treating heart failure.. SEMIN CARDIOTHORAC VASC ANESTH 10: 228-230 [Abstract]  
  • Stanley, W. C., Recchia, F. A., Lopaschuk, G. D. (2005). Myocardial Substrate Metabolism in the Normal and Failing Heart. Physiol. Rev. 85: 1093-1129 [Abstract] [Full Text]  
  • Fang, Z. Y., Prins, J. B., Marwick, T. H. (2004). Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications. Endocr. Rev. 25: 543-567 [Abstract] [Full Text]  
  • Nikolaidis, L. A, Sturzu, A., Stolarski, C., Elahi, D., Shen, Y.-T., Shannon, R. P (2004). The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc Res 61: 297-306 [Abstract] [Full Text]  
  • Miche, E., Radzewitz, A., Notohamiprodjo, G., Baller, D., Kloppe, A., Eckert, S., Gleichmann, U. (2002). [123I]-phenylpentadecanoic acid uptake in patients with dilated cardiomyopathy. Eur J Heart Fail 4: 431-438 [Abstract] [Full Text]  
  • Davila-Roman, V.i. G., Vedala, G., Herrero, P., de las Fuentes, L., Rogers, J. G., Kelly, D. P., Gropler, R. J. (2002). Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 40: 271-277 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.